Opus Genetics, Inc. (NASDAQ:IRD) reported on September 9 that all five low-dose BIRD-1 participants showed clinically ...

Cadwell brings more than 20 years of experience in the fats and oils industry. Select Genetics is pleased to announce that ...

SOPHiA GENETICS is back in focus as analysts reset their central price views, with fair value moving from US$9.00 to US$9.75.

SOPHiA GENETICS SA is entering a scale-and-monetise phase, with its genomic intelligence platform. Check out more on SOPH ...

The average one-year price target for Myriad Genetics (NASDAQGS:MYGN) has been revised to $3.43 / share. This is a decrease of 16.18% from the prior estimate of $4.10 dated August 25, 2026. These ...

The average one-year price target for Opus Genetics (NASDAQCM:IRD) has been revised to $12.98 / share. This is an increase of 21.47% from the prior estimate of $10.68 dated August 25, 2026. These ...

It turns out my status as an alcohol lightweight is likely dictated by my genes. Scientists have long known that excessive ...

Opus Genetics (IRD) receives a Buy rating following >30% stock surge on positive Phase 1/2 data for OPGx-BEST1 in ...

Myriad Genetics Inc. company and executive profile by Barron's. View the latest MYGN company infomation and executive bios.

BACKGROUND: Evidence of the diverse genetic architecture of dilated cardiomyopathy (DCM) continues to emerge and requires ...

A person’s genetic background can strongly influence not only whether they will develop cancer but also how that cancer progresses, suggesting that genetics plays a much larger role in cancer ...

A genetic testing company's data breach is particularly problematic for people undergoing IVF, experts warned.